TY - JOUR
T1 - Interactions between HIF-1 and Jab1
T2 - Balancing apoptosis and adaptation - Outline of a working hypothesis
AU - Larsen, Mona
AU - Høg, Anja
AU - Lund, Eva L.
AU - Kristjansen, Paul E.G.
PY - 2005
Y1 - 2005
N2 - When cells experience hypoxia, they either die by apoptosis or adapt to the hypoxic conditions by a series of compensatory mechanisms. Hypoxia inducible factor-1 (HIF-1) is a transcription factor involved in both processes, but the exact mechanisms regulating whether the cells survive (adapt) or perish by apoptosis are largely unknown. We hypothesize that the balancing between apoptosis and adaptation is governed by a triangular feedback system involving the α-subunit of HIF-1, p53, and jun activating binding protein 1 (Jab1). Jab1 and p53 bind competitively to the same domain on HIF-1α resulting in either stabilization or degradation of HIF-1α, respectively. Moreover, p53 is stabilized by binding to HIF-1α, whereas its interaction with Jab1 targets p53 for degradation. Thus as a consequence we propose that the ratio between p53 and Jab1 determine whether a hypoxic induction of HIF-1 results in apoptosis or adaptation, with Jab1 as the factor promoting adaptation. On this background we consider Jab1 an interesting molecular target for anticancer therapy.
AB - When cells experience hypoxia, they either die by apoptosis or adapt to the hypoxic conditions by a series of compensatory mechanisms. Hypoxia inducible factor-1 (HIF-1) is a transcription factor involved in both processes, but the exact mechanisms regulating whether the cells survive (adapt) or perish by apoptosis are largely unknown. We hypothesize that the balancing between apoptosis and adaptation is governed by a triangular feedback system involving the α-subunit of HIF-1, p53, and jun activating binding protein 1 (Jab1). Jab1 and p53 bind competitively to the same domain on HIF-1α resulting in either stabilization or degradation of HIF-1α, respectively. Moreover, p53 is stabilized by binding to HIF-1α, whereas its interaction with Jab1 targets p53 for degradation. Thus as a consequence we propose that the ratio between p53 and Jab1 determine whether a hypoxic induction of HIF-1 results in apoptosis or adaptation, with Jab1 as the factor promoting adaptation. On this background we consider Jab1 an interesting molecular target for anticancer therapy.
UR - http://www.scopus.com/inward/record.url?scp=33646869916&partnerID=8YFLogxK
U2 - 10.1007/0-387-26206-7_28
DO - 10.1007/0-387-26206-7_28
M3 - Journal article
C2 - 16594154
AN - SCOPUS:33646869916
SN - 0065-2598
VL - 566
SP - 203
EP - 211
JO - Advances in Experimental Medicine and Biology
JF - Advances in Experimental Medicine and Biology
ER -